Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone P Niclou

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|June 1, 2013
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor statusMikael Johansson, Anaïs Oudin, Katja Tiemann, et al.
Plos One|May 2, 2015
Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastomaMorgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, et al.
Molecular and Cellular Neurosciences|December 31, 2003
The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathwaysMorven C Shearer, Simone P Niclou, David Brown, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Molecular and Cellular Neurosciences|May 9, 2006
The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron diseaseFred De Winter, Tam Vo, Floor J Stam, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 20, 2017
Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastomaNina Obad, Heidi Espedal, Radovan Jirik, et al.
Cells|June 21, 2019
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor MicroenvironmentNathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
British Journal of Cancer|August 11, 2017
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9ASiti Aminah Abdul Rahim, Anne Dirkse, Anais Oudin, et al.
Scientific Reports|February 21, 2020
Fisetin protects against cardiac cell death through reduction of ROS production and caspases activitySophie Rodius, Niek de Klein, Céline Jeanty, et al.
Proteome Science|July 31, 2014
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in cultureUros Rajcevic, Jaco C Knol, Sander Piersma, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|June 1, 2013
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor statusMikael Johansson, Anaïs Oudin, Katja Tiemann, et al.
Plos One|May 2, 2015
Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastomaMorgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, et al.
Molecular and Cellular Neurosciences|December 31, 2003
The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathwaysMorven C Shearer, Simone P Niclou, David Brown, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Molecular and Cellular Neurosciences|May 9, 2006
The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron diseaseFred De Winter, Tam Vo, Floor J Stam, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 20, 2017
Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastomaNina Obad, Heidi Espedal, Radovan Jirik, et al.
Cells|June 21, 2019
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor MicroenvironmentNathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
British Journal of Cancer|August 11, 2017
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9ASiti Aminah Abdul Rahim, Anne Dirkse, Anais Oudin, et al.
Scientific Reports|February 21, 2020
Fisetin protects against cardiac cell death through reduction of ROS production and caspases activitySophie Rodius, Niek de Klein, Céline Jeanty, et al.
Proteome Science|July 31, 2014
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in cultureUros Rajcevic, Jaco C Knol, Sander Piersma, et al.
Pageof 13